We use cookies for authentication, analytics, and (with your consent) advertising measurement. You can accept all, reject non-essential, or customize. Learn more

Back to Market Insider
Vol. I · 2026
Rev. Blue
Issue UNIVERSAL-01
Buyer / Distributor
LIVE · ACTIVE 90D
Moderate activity
Updated

Universal

Universal is deep in post-production on Wicked: For Good while simultaneously managing a franchise rights acquisition and a broad slate of incoming titles across genres.

§ 01
Activity
12wk volume

Each signal is one documented data point captured by our continuous pipeline: a trade-press mention, festival market activity, executive statement, or acquisition activity update. Higher signal volume means Universal is generating more public market activity right now.

30 days
6
-11 vs prior
90 days
31
signals captured
12 months
266
cumulative
Last signal
May 21·2026
pipeline pulse
§ 02
Current snapshot
Tracked decision makers
129
Decision Makers on Record
Active acquisition network across 266 records in the past 12 months

"Chu identifies Elphaba and Glinda as superhero-like figures and frames Wicked: For Good partly as a monster movie and origin story, indicating a tone that blends spectacle with character-driven drama."

Current snapshot
Updated May 21
Most recent signal
Baby Monster
Acquired
Top genre focus
Not disclosed
mix not yet established
Territory
North America + intl.
distribution + acquisitions
Access pattern
Rep-only
festival-driven discovery
See your match in the app
§ 03
Current mandate
Editorial analysis · updated continuously

Universal's most visible current position is the theatrical rollout of Wicked: For Good, the second part of Jon M. Chu's two-film adaptation, scheduled for release November 21. Director Chu re-edited the film after observing audience response to the first installment's late 2024 release, added new dialogue, and organized UK reshoots with Cynthia Erivo and Ariana Grande as recently as March. The studio's recent landmark acquisition of The Exorcist franchise rights, reported at $400M, signals a parallel commitment to horror properties with proven audience reach.

Over the past twelve months, Universal has logged 266 tracked records, reflecting sustained acquisition and development activity. Recent deals include Baby Monster (November 2025) and King: A Life (May 2025), alongside the Exorcist franchise purchase. The studio's content focus consistently gravitates toward horror and thriller material with strong audience appeal, as well as projects featuring rich world-building and character depth capable of supporting immersive, multi-platform experiences. The Wicked franchise itself exemplifies the studio's appetite for spectacle-driven, character-led narratives that can sustain long production cycles and late-stage creative refinement.

Access to Universal's acquisitions pipeline runs primarily through its tracked decision-maker network, which currently spans 129 individuals. Unsolicited submissions are not a standard entry point; representation and festival positioning remain the most reliable pathways for independent projects seeking consideration.

§ 04
Signature peaks
Exorcist Franchise Acquisition
$400M
Horror franchise rights acquired January 2025
12-Month Activity
266
Total tracked records over the past 12 months
Decision Maker Network
129
Unique decision makers currently tracked at Universal
§ 05
Mandate dimensions
5 dimensions
Genre focus
Territory focus
Not disclosed
Budget tier (observed)
Not disclosed
Access pattern
Access runs through representation. With 129 tracked decision makers, Universal has one of the broader institutional footprints in the market, but the studio does not accept unsolicited material. Agent, manager, or entertainment attorney relationships are the primary route. Festival premieres with strong genre credentials, particularly in horror and thriller, represent a secondary pathway. Producer attachments with prior Universal history improve the odds of a project reaching the right desk.
Deal structure
Acquisition terms at Universal are not consistently disclosed. The Exorcist franchise rights deal was reported at $400M. Baby Monster and King: A Life were acquired at undisclosed terms. The studio has demonstrated willingness to structure deals around franchise potential, long production cycles, and late-stage creative flexibility, as seen in the Wicked two-film production model where additional shooting capacity was built into the original deal structure.
§ 06
Recent acquisitions
3 signals · trade-press sourced

Baby Monster

2025-11-07T00:00:00.000Z
Acquired

King: A Life

2025-05-01T00:00:00.000Z
Acquired

The Exorcist franchise rights

2025-01-01T00:00:00.000Z
Acquired
§ 07
Market context

"Chu identifies Elphaba and Glinda as superhero-like figures and frames Wicked: For Good partly as a monster movie and origin story, indicating a tone that blends spectacle with character-driven drama."

ScriptMatch desk

Universal's most visible current position is the theatrical rollout of Wicked: For Good, the second part of Jon M. Chu's two-film adaptation, scheduled for release November 21. Director Chu re-edited the film after observing audience response to the first installment's late 2024 release, added new dialogue, and organized UK reshoots with Cynthia Erivo and Ariana Grande as recently as March. The studio's recent landmark acquisition of The Exorcist franchise rights, reported at $400M, signals a parallel commitment to horror properties with proven audience reach.

§ 08
The next step
Open the app
LIVE MATCHING ENGINE
4,103 active buyers indexed

You just read about Universal.
Now find out if Universal should be reading you.

This page is a public snapshot of Universal, kept fresh from trade-press signals. ScriptMatch is the live market-data engine behind it. Upload your script, and we use the same continuously-indexed buyer activity to tell you which production companies and distributors are actively acquiring projects like yours right now, why each one fits, and exactly how to reach them.

AI script-to-buyer matching
Your script analyzed against 4,103+ active indie buyers. Match scores show which ones genuinely fit, not just a generic directory.
Executive email enrichment
Verified email lookups for the specific development executives at each matched buyer. Reach the right person, not a general inbox.
Script tracking + pathway playbook
Per-script outreach tracking, pathway recommendations (festival, rep, producer, direct), and a tailored "how to approach" guide for every matched buyer.
Live market alerts
Get notified when Universal or any matched buyer closes a deal that signals appetite for projects like yours.
What the free trial unlocks
  • Your first 10 AI-matched buyers for your script, with match rationale and pathway recommendations
  • Full access to the buyer intelligence layer — recent acquisitions, executive moves, stated mandates
  • Email enrichment for matched development executives
  • Script tracking dashboard + market alerts for 7 days
Start free 7-day trial
No credit card · Cancel anytime · Unlimited scripts
§ 10
Common questions
6 answered
Q01

Does Universal accept unsolicited scripts?

Universal does not operate an open submission pipeline for unsolicited scripts. The studio's acquisitions activity, reflected in 266 tracked records over the past 12 months, flows through established relationships with agents, producers, and attorneys. Writers without representation should prioritize securing agency or management before approaching Universal. Festival premieres have historically served as a secondary entry point for independent projects that attract the studio's attention organically.

Q02

What budgets does Universal typically work with for acquisitions?

Universal operates across a wide budget range. The acquisition of The Exorcist franchise rights was reported at $400M, reflecting the studio's willingness to commit significant capital to proven IP. Titles such as Baby Monster and King: A Life were acquired at undisclosed terms, suggesting the studio also moves on projects where deal specifics are not publicly announced. Budget expectations vary considerably by project type, genre, and existing IP value.

Q03

Does Universal acquire films out of festivals?

Festival positioning is a recognized pathway into Universal's acquisition consideration, particularly for genre projects with strong audience and critical response. The studio's content focus on horror and thriller material with demonstrated audience appeal aligns well with the kind of market buzz that major festivals generate. While no specific festival acquisition has been confirmed in the current 30 to 90 day window, the studio's broader 12-month record of 266 tracked activities indicates ongoing market engagement.

Q04

How do you reach Universal's acquisitions team?

Universal's acquisitions and development activity is tracked across 129 decision makers, making it one of the larger institutional networks in the market. The most reliable access pathway is through representation, specifically agents, managers, or entertainment attorneys with existing Universal relationships. Producer attachments with prior Universal credits also improve access. Cold outreach directly to the studio is not a standard or recommended approach for unrepresented writers or filmmakers.

Q05

What genres is Universal focused on right now?

Universal's current content focus centers on horror and thriller projects with strong audience appeal and critical credibility, as evidenced by the $400M acquisition of The Exorcist franchise rights in January 2025. The studio also pursues projects with rich world-building and character depth capable of supporting immersive experiences, a mandate reflected in the Wicked franchise. Director Jon M. Chu has framed Wicked: For Good partly as a monster movie and origin story, suggesting the studio values genre hybridity alongside spectacle.

Q06

Is Universal currently active in acquisitions?

Yes. Universal has logged 266 tracked records over the past 12 months and has confirmed acquisitions including Baby Monster (November 2025), King: A Life (May 2025), and The Exorcist franchise rights (January 2025). The most recent tracked signal is dated May 21, 2026. While unique deal counts in the 30 and 90 day windows currently show no confirmed closed transactions, deal velocity in the 30-day window is tracked at 2, indicating continued market activity.

§ 11
Colophon
Methodology

Profile compiled from publicly-available sources: trade press (Deadline, Variety, IndieWire, The Hollywood Reporter, Screen Daily), festival market reports (Cannes Marche, AFM, EFM, TIFF Industry), executive public statements, and acquisition announcements. Activity counters reflect signal volume from continuous pipeline indexing.

Corrections

See an inaccuracy? Suggest a correction. Profiles update continuously as new public information becomes available.

ScriptMatch · Buyer Profile · UNIVERSAL
Vol. I · 2026 · Rev. Blue